Characterization of Estrogen Receptor Low Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

被引：0
|
作者：
Li, Ming [1 ]
Lv, Hong [1 ]
Shui, Ruohong [1 ]
Lu, Hongfen [1 ]
Yang, Wentao [1 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
137
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] Characterization of Estrogen Receptor Low Positive/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
    Li, Ming
    Lv, Hong
    Shui, Ruohong
    Lu, Hongfen
    Yang, Wentao
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 151 - 151
  • [2] Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors
    Groheux, David
    Hatt, Mathieu
    Hindie, Elif
    Giacchetti, Sylvie
    de Cremoux, Patricia
    Lehmann-Che, Jacqueline
    Martineau, Antoine
    Marty, Michel
    Cuvier, Caroline
    Cheze-Le Rest, Catherine
    de Roquancourt, Anne
    Visvikis, Dimitris
    Espie, Marc
    CANCER, 2013, 119 (11) : 1960 - 1968
  • [3] Multitargeted therapy in estrogen receptor-positive, human epidermal growth factor receptor-2-positive breast cancer
    Nahleh, ZA
    Jazieh, AR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 631 - 633
  • [4] Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer
    Rios-Hoyo, Alejandro
    Cobain, Erin
    Huppert, Laura A.
    Beitsch, Peter D.
    Buchholz, Thomas A.
    Esserman, Laura
    van't Veer, Laura J.
    Rugo, Hope S.
    Pusztai, Lajos
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (22)
  • [5] Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer
    Kim, HJ
    Cui, XJ
    Hilsenbeck, SG
    Lee, AV
    CLINICAL CANCER RESEARCH, 2006, 12 (03) : 1013S - 1018S
  • [6] Recent Advances in Adjuvant Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
    Cobain, Erin F.
    Hayes, Daniel F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (32) : 3673 - +
  • [7] Human epidermal growth factor receptor 2 status in breast cancer: A comparison between borderline positive human epidermal growth factor receptor 2 and strongly positive human epidermal growth factor receptor 2 tumors
    Huszno, Joanna
    Nowara, Elibieta
    CLINICAL CANCER INVESTIGATION JOURNAL, 2015, 4 (03): : 307 - 311
  • [8] Management of hormone receptor–positive, human epidermal growth factor 2–negative metastatic breast cancer
    Jason A. Mouabbi
    C. Kent Osborne
    Rachel Schiff
    Mothaffar F. Rimawi
    Breast Cancer Research and Treatment, 2021, 190 : 189 - 201
  • [9] Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer
    Honda, Chikako
    Kurozumi, Sasagu
    Katayama, Ayaka
    Hanna-Khalil, Bishoy
    Masuda, Kei
    Nakazawa, Yuko
    Ogino, Misato
    Obayashi, Sayaka
    Yajima, Reina
    Makiguchi, Takaya
    Oyama, Tetsunari
    Horiguchi, Jun
    Shirabe, Ken
    Fujii, Takaaki
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (06)
  • [10] Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer
    Rugo, Hope S.
    Delord, Jean-Pierre
    Im, Seock-Ah
    Ott, Patrick A.
    Piha-Paul, Sarina A.
    Bedard, Philippe L.
    Sachdev, Jasgit
    Le Tourneau, Christophe
    van Brummelen, Emilie M. J.
    Varga, Andrea
    Salgado, Roberto
    Loi, Sherene
    Saraf, Sanatan
    Pietrangelo, Dina
    Karantza, Vassiliki
    Tan, Antoinette R.
    CLINICAL CANCER RESEARCH, 2018, 24 (12) : 2804 - 2811
12345